ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,163.67
-0.63%
Dow Jones
38,647.10
-0.17%
Gold vs US Dollar
2,305.235
0.12%
Brent Oil
82.14
0.20%
Bitcoin
66,721.78
-0.05%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. VYNE Therapeutics Inc (VYNE) Share Price

VYNE VYNE Therapeutics Inc

2.20
0.05 (2.33%)
14 Jun 2024 - Closed
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 VYNE Therapeutics Inc NASDAQ:VYNE NASDAQ Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   0.05 2.33 2.20 1.92 2.96 2.3076 2.00 2.16 96,980 00:00:00   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Pharmaceutical Preparations 424k -28.45M -2.0180 -1.07 30.45M
 Type  Size  Price  Time  Units 
 20 246 2.20 20:07:09 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore VYNE News
04/06/202421:30EDGAR2Form 4 - Statement of changes in beneficial ownership of securities
09/05/202421:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/05/202413:00EDGAR2Form 8-K - Current report
01/03/202422:16EDGAR2Form S-3 - Registration statement under Securities Act of 1933
01/03/202422:15EDGAR2Form S-8 - Securities to be offered to employees in employee benefit plans
29/02/202413:12EDGAR2Form 8-K - Current report
02/02/202414:42EDGAR2Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Period
Draw mode
Data Downloads for VYNE

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest VYNE Therapeutics Inc Articles